Zobrazeno 1 - 10
of 15
pro vyhledávání: '"J. R. Azpiri-López"'
Autor:
N. Guajardo-Jauregui, D. Á. Galarza-Delgado, J. R. Azpiri-López, I. J. Colunga-Pedraza, A. Cárdenas, A. N. Garza-Cisneros, A. Garcia-Heredia, M. A. Balderas-Palacios, A. B. Rodriguez-Romero
Publikováno v:
Annals of the Rheumatic Diseases. 81:1237.2-1238
BackgroundCardiovascular (CV) disease is the major cause of death of RA patients. There is a direct association of systemic inflammation and an accelerated process of atherosclerosis, which is related to higher CV morbimortality (1). Additionally, RA
Autor:
N. Guajardo-Jauregui, J. R. Azpiri-López, I. J. Colunga-Pedraza, D. Á. Galarza-Delgado, A. Cárdenas, A. N. Garza-Cisneros, A. Garcia-Heredia, M. A. Balderas-Palacios, A. B. Rodriguez-Romero
Publikováno v:
Annals of the Rheumatic Diseases. 81:1398.2-1399
BackgroundSystemic lupus erythematosus (SLE) patients have a worse cardiovascular prognosis than the general population. It is estimated that approximately 40% of SLE patients develop lupus nephritis (LN) throughout the evolution of the disease (1).
Autor:
M. A. Balderas-Palacios, I. J. Colunga-Pedraza, D. Á. Galarza-Delgado, J. R. Azpiri-López, A. B. Rodriguez-Romero, A. N. Garza-Cisneros, A. Garcia-Heredia, N. Guajardo-Jauregui, A. Cárdenas
Publikováno v:
Annals of the Rheumatic Diseases. 81:1228.2-1228
BackgroundThe main cause of death in patients with rheumatoid arthritis (RA) is due to cardiovascular disease1. Cardiovascular mortality is strongly associated with the cumulative severity of the disease. Functional disability, as measured by the Hea
Autor:
N. Guajardo-Jauregui, I. J. Colunga-Pedraza, D. Á. Galarza-Delgado, J. R. Azpiri-López, A. Cárdenas, A. N. Garza-Cisneros, A. Garcia-Heredia, M. A. Balderas-Palacios, A. B. Rodriguez-Romero
Publikováno v:
Annals of the Rheumatic Diseases. 81:553.2-554
BackgroundCurrent EULAR recommendations for cardiovascular risk (CVR) assessment in rheumatoid arthritis (RA) indicate that the CVR evaluation should be performed according to national guidelines; however, there was no algorithm designed for the Mexi
Autor:
A. N. Garza-Cisneros, I. J. Colunga-Pedraza, D. Á. Galarza-Delgado, J. R. Azpiri-López, A. B. Rodriguez-Romero, M. A. Balderas-Palacios, A. Garcia-Heredia, N. Guajardo-Jauregui, A. Cárdenas, D. E. Flores Alvarado
Publikováno v:
Annals of the Rheumatic Diseases. 81:1274.1-1274
BackgroundObesity plays an important role in autoimmune and inflammatory diseases such as rheumatoid arthritis (RA). It has been demonstrated a paradoxical relationship between increased body mass index (BMI) and disease activity (1). Acute phase rea
Autor:
M. A. Balderas-Palacios, J. R. Azpiri-López, D. Á. Galarza-Delgado, I. J. Colunga-Pedraza, A. N. Garza-Cisneros, A. Garcia-Heredia, N. Guajardo-Jauregui, A. B. Rodriguez-Romero, A. Cárdenas
Publikováno v:
Annals of the Rheumatic Diseases. 81:1387.1-1387
BackgroundSystemic lupus erythematosus (SLE) is an autoimmune disease with a high prevalence worldwide. Patients with SLE have a higher frequency of developing cardiovascular disease than the general population. There is little evidence on conduction
Autor:
N. Guajardo-Jauregui, J. R. Azpiri-López, I. J. Colunga-Pedraza, D. Á. Galarza-Delgado, A. Cárdenas, A. N. Garza-Cisneros, A. Garcia-Heredia, M. A. Balderas-Palacios, A. B. Rodriguez-Romero
Publikováno v:
Annals of the Rheumatic Diseases. 81:1399-1399
BackgroundSystemic lupus erythematosus (SLE) is an autoimmune inflammatory disease. Patients with SLE have higher risk of developing a cardiovascular event than the general population (1), with multiple factors contributing to this increased risk, in
Autor:
A. N. Garza-Cisneros, I. J. Colunga-Pedraza, D. Á. Galarza-Delgado, J. R. Azpiri-López, A. B. Rodriguez-Romero, M. A. Balderas-Palacios, A. Garcia-Heredia, N. Guajardo-Jauregui, A. Cárdenas
Publikováno v:
Annals of the Rheumatic Diseases. 81:1228.3-1229
BackgroundRheumatoid arthritis (RA) is a chronic, autoimmune, inflammatory disease in which cardiovascular disease is the leading cause of death (1). Exercise has been shown to have certain benefits in chronic diseases such as RA, decreasing symptoms
Autor:
A. N. Garza-Cisneros, D. Á. Galarza-Delgado, J. R. Azpiri-López, I. J. Colunga-Pedraza, M. A. Balderas-Palacios, A. Garcia-Heredia, N. Guajardo-Jauregui, A. B. Rodriguez-Romero, A. Cárdenas
Publikováno v:
Annals of the Rheumatic Diseases. 81:1387.2-1388
BackgroundRheumatoid cachexia is a clinical spectrum of rheumatoid arthritis in which individuals present increased inflammatory activity, more aggressive joint destruction, and worse cardiovascular prognosis (1). Systemic lupus erythematosus (SLE) i
Autor:
A. N. Garza-Cisneros, D. Á. Galarza-Delgado, J. R. Azpiri-López, I. J. Colunga-Pedraza, M. A. Balderas-Palacios, A. Garcia-Heredia, N. Guajardo-Jauregui, A. B. Rodriguez-Romero, A. Cárdenas, D. E. Flores Alvarado
Publikováno v:
Annals of the Rheumatic Diseases. 81:1600.2-1600
BackgroundPsoriatic arthritis (PsA) is associated with an increased prevalence of cardiovascular events due to accelerated atherosclerosis that seems to depend on traditional and non-traditional risk factors(1). There is a positive correlation betwee